**Hims & Hers Health, Inc. (HIMS)** has experienced a significant stock increase of **67%** over the past month, outperforming the Zacks S&P 500 composite’s rise of **3.5%**. In contrast, the Zacks Medical Info Systems industry has seen a decline of **1.5%** during the same period. Analysts have projected Hims & Hers will report earnings of **$0.05** per share for the current quarter, representing a **266.7%** increase year-over-year, with full-year estimates indicating growth of **263.6%**.
The company’s revenue for the last reported quarter reached **$278.17 million**, marking a **45.8%** year-over-year increase and a **2.76%** surprise over the Zacks Consensus Estimate of **$270.7 million**. Looking forward, the consensus sales estimate stands at **$295.32 million** for the current quarter, reflecting an anticipated **42%** increase year-over-year, and projections for fiscal years are estimated at **$1.23 billion** and **$1.54 billion**, signifying growth of **40.6%** and **25.8%**, respectively.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
